Mendine Erythronet Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 28-06-2024
- Paid Up Capital ₹ 0.10 M
as on 28-06-2024
- Company Age 9 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 188.72%
(FY 2022)
- Profit -189.13%
(FY 2022)
- Ebitda -240.58%
(FY 2022)
- Net Worth -85.00%
(FY 2022)
- Total Assets 18.35%
(FY 2022)
About Mendine Erythronet
The Company is engaged in the Information Technology Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Probhas Chakraborty, Kalpana Chakraborty, and Srijani Lahiri serve as directors at the Company.
- CIN/LLPIN
U74900WB2015PTC206295
- Company No.
206295
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 May 2015
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Mendine Erythronet?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Probhas Chakraborty  | Director | 11-May-2015 | Current |
| Kalpana Chakraborty | Director | 11-May-2015 | Current |
| Srijani Lahiri | Additional Director | 25-Jan-2022 | Current |
Financial Performance of Mendine Erythronet.
Mendine Erythronet Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 188.72% increase. The company also saw a substantial fall in profitability, with a 189.13% decrease in profit. The company's net worth observed a substantial decline by a decrease of 85%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mendine Erythronet?
In 2019, Mendine Erythronet had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Mendine Lifecare Products Private LimitedActive 14 years 10 monthsProbhas Chakraborty, Kalpana Chakraborty and 1 more are mutual person
- Mendine Pharmaceuticals Pvt LtdActive 48 years 11 months
Probhas Chakraborty, Kalpana Chakraborty and 1 more are mutual person
Inner Eye Consultancy Services LlpActive 5 years 2 monthsProbhas Chakraborty and Kalpana Chakraborty are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Mendine Erythronet?
Unlock and access historical data on people associated with Mendine Erythronet, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mendine Erythronet, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mendine Erythronet's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
